Stock Price Quote

PAN DRUGS LTD.

NSE : NABSE : 531440ISIN CODE : Industry : Pharmaceuticals & DrugsHouse : Private
BSE2.050 (0 %)
PREV CLOSE ( ) 2.05
OPEN PRICE ( ) 2.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )2.05 2.05
52 WK LOW / HIGH ( ) 00
NSE
This Company is not listed in NSE
BSE NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1993
Management Info
- Chairman Kamal Natvarlal Pandya - Managing Director
Registered Office

Address 167 - 168,G I D C , Industrial Estate,Nandesari,
Vadodara,
Gujarat-391340

Phone 0265 - 2840739/2840740/2840741

Email pandrugs@gmail.com

Website -

Registrars Details
Pan Drugs Ltd.
167, Gidc Industrial Estate, Nandesari,Baroda
 Listing : BSE

NEWS

08Jan Pan Drugs submits shareholding pattern
Pan Drugs has submitted the Shareholding Pattern for the Period Ended De..
15May Pan Drugs submits shareholding pattern
Pan Drugs has submitted the Shareholding Pattern for the Period Ended Ma..
09Feb Pan Drugs informs about closure of tra
Pan Drugs has informed that a meeting of the Board of Directors of the C..
09Oct Pan Drugs informs about standalone fin
Pan Drugs has informed about the standalone financial results for the pe..
04Apr Pan Drugs informs about appointment of
Pan Drugs has now informed that Arvind Narharibhai Brahmbhatt, the Manag..
MORE

Financials

in Millions
QTR Dec 15 ANNUAL 15
Net Profit-0.79-0.59
Gross Profit -0.79 -0.59
Operating Profit 1.2412.01
Net Sales 55.73353.66
MORE

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Solara Active Pharma (BSE)
peergroup  719.65 (5.79%)
M.Cap ( in Cr)1857.74
Jenburkt Pharma (BSE)
peergroup  409.00 (10.21%)
M.Cap ( in Cr)187.71
Astrazeneca Pharma I (BSE)
peergroup  2829.00 (0.96%)
M.Cap ( in Cr)7072.50
Ajanta Pharma (BSE)
peergroup  1471.35 (1.75%)
M.Cap ( in Cr)12643.29
IOL Chem & Pharma (BSE)
peergroup  259.60 (10.19%)
M.Cap ( in Cr)1447.79
MORE

Shareholding Pattern

NON-INSTITUTION 60.64%
PROMOTERS 39.36%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%
MORE

Mf Holdings

Scheme NameHold(%)
No Data Found

About Pan Drugs Ltd.

Pan Drugs Ltd. was incorporated in the year 1993. Its today's share price is 2.05. Its current market capitalisation stands at Rs 0.64 Cr. In the latest quarter, company has reported Gross Sales of Rs. 346.41 Cr and Total Income of Rs.317.38 Cr. The company's management includes Kashmira Atulbhai Pandya, Parag Vamanray Raval, Kamal Natvarlal Pandya, Atul Natwarlal Pandya, Sudhirkumar Anantprakash Dhingra, Hemant Upadhyay.

It is listed on the BSE with a BSE Code of 531440 , NSE with an NSE Symbol of and ISIN of . It's Registered office is at 167 - 168,G I D C , Industrial Estate,NandesariVadodara-391340, Gujarat. Their Registrars are ACC Ltd. It's auditors are SG Bhagwat & Co

download beyond app
About Nirmal Bang About Nirmal Bang Awards & Accolades Careers at Nirmal Bang Contact Nirmal Bang
Product & Services Equity & Derivatives Trading Forex Trading Commodity Trading Institutional Broking Depository Services Margin Funding Algo Trading
Equity Price Analysis Volume Analysis Index Analysis News Analysis Corporate Action India Market Other Market Share Market Holidays
Derivatives Updates Market Report Overview
IPO IPO Issues Performance News & Analysis
Commodities Market Movers News & Commentary MCX / NCDEX Holidays
Mutual Funds About Nirmal Bang Wealth Why Associate with Nirmal Bang Mutual Fund Login Mutual Fund Register FAQs Mutual Fund Holidays SIP Calculator Mutual Funds Updates Mutual Funds Trends Mutual Fund Reports Annual Return 2018 Annual Return 2017 Mutual Fund Terms & Conditions Mutual Privacy Policy
Nirmal Bang Research Technical Calls Equity Reports Commodity Reports Currency Research Institutional Research
Nirmal Bang Media Knowledge Center Blog Support Center Become A Partner Beyond Market Careers Sitemap
Other Links Disclaimer Privacy Policy Terms Of Use Rules & Regulations Disclosures Grievances SEBI ScoresRMS Policy
Connect with Us
ATTENTION INVESTORS Depository IPO KYC
Inactive account treatmentNBSPL Policy of AMLNBEPL Policy of AMLNBCPL Policy of AMLNBSPL CSR Policy Physical Settlement Policy of Derivative Aadhar UpdationNirmalbang Privacy Policy V1.0 Documents in Vernacular Languages NBSPL Disclosure Document March 2019
Nirmal Bang Securities Pvt. Ltd. : Member NSE – ID 09391, SEBI Registration No. NSE CM Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE FO Segment INZ000202536, Member NSE – ID 09391, SEBI Registration No. NSE CDS Segment INZ000202536, Member NSE Commodity – ID 09391, SEBI Registration No. NSE COMMODITY Segment Exchange Registered Broker, Member MSEI – ID 1067, SEBI Registration No. MSEI CM Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI FO Segment INZ000202536, Member MSEI – ID 1067, SEBI Registration No. MSEI CDS Segment INZ000202536, Member MCX – ID 56460, SEBI Registration No. MCX COMMODITY Segment INZ000202536, Member NCDEX – ID 1268, SEBI Registration No. NCDEX COMMODITY Segment NZ000202536, Member ICEX – ID 2073, SEBI Registration No. ICEX COMMODITY Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CM Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE FO Segment INZ000202536, Member BSE – ID 0498, SEBI Registration No. BSE CDS Segment Exchange Registered Broker, Member BSE Commodity – ID 0498, SEBI Registration No. BSE COMMODITY Segment Exchange Registered Broker, SEBI Registration No. PMS INP000002981, SEBI Registration No. Research Analyst INP000002981, SEBI Registration No. DP Participants NSDL – CDSL IN-DP-CDSL 37-99,Member Comtrack Participant Id – ID 50274, Member NERL RP Id– ID R1447, Nirmal Bang Equities Private Limited Member BSE – ID 245, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. BSE CM Segment INZ000186135, Member NSE – ID 13437, SEBI Registration No. NSE FO Segment INZ000186135, Member NSE Currency – ID 13437, SEBI Registration No. NSE CDS Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI CM Segment INZ000186135, Member MSEI – ID 17780, SEBI Registration No. MSEI FO Segment INZ000186135, SEBI Registration No. Research Analyst Segment INH000001436, Nirmal Bang Commodities Private Limited Member MCX – ID 16590, SEBI Registration No. MCX COMMODITY Segment INZ000043630, Member NCDEX – ID 00362, SEBI Registration No. NCDEX COMMODITY Segment INZ000043630, Member ICEX – ID 1165, SEBI Registration No. ICEX COMMODITY Segment INZ000043630, Member NCDEX Spot Exchange – ID 10084,Comtrack Participant CPID -5040, Participant CDSL Commodity Repository Limited - 12013300
For any grievances, please get in touch on 022-62739390 and write a mail to Contact@nirmalbang.com with Subject line as Grievances/Complain.     |    

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X
AppleApp Store GooglePlay Store
AppleApp StoreGooglePlay Store
Support
Videos